Menopause Home > Important Information on Climara Pro Indications

Using Climara Pro for Osteoporosis Prevention

Because estrogen helps to keep the bones strong, the decrease in estrogen during menopause causes a significant weakening of the bones, often resulting in osteoporosis. By providing estrogen, Climara Pro can help prevent these menopause-related bone changes. However, hormone replacement therapy is not risk-free, and it should only be used in women at significant risk for osteoporosis. Also, other, non-hormonal medications to prevent osteoporosis should be seriously considered before Climara Pro is used.

Climara Pro Use in Children and Teens

Climara Pro is not approved for use in children or teens. Discuss the risks and benefits of using Climara Pro with your child's healthcare provider.

Off-Label Climara Pro Uses

On occasion, your healthcare provider may recommend Climara Pro for something other than the conditions listed in this article. This is called an "off-label" use. At one point, hormone replacement therapy was used off-label for preventing heart disease and dementia (such as Alzheimer's disease), but these are no longer considered legitimate off-label uses. Sometimes hormones are used to promote youthfulness. Again, this is not generally accepted as a legitimate off-label Climara Pro use.
Using Climara Pro to treat menopause symptoms other than night sweats or hot flashes would be an off-label use of the drug.
Written by/reviewed by:
Last reviewed by: Kristi Monson, PharmD;
Last updated/reviewed:
List of references (click here):
Other Articles in This eMedTV Presentation

Topics & Medications


Related Channels

eMedTV Links
Copyright © 2006-2020 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.